Clinical Trial Update: Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 2 study evaluating imatinib combined with chemotherapy for BCR-ABL–positive acute lymphoblastic leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Japan Adult Leukemia Study Group | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED